Evidence map›Paper›PMID 32582302›Full record

ArticleFrontiers in genetics2020

Lack of Association Between Genetic Variants at

Esteban A Lopera Maya, Adriaan van der Graaf, Pauline Lanting, Marije van der Geest, Jingyuan Fu, Morris Swertz, Lude Franke, Cisca Wijmenga, Patrick Deelen, Alexandra Zhernakova and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Host polymorphisms and COVID-19 infection.Advances in clinical chemistry · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Population-SpecificViruses · 2021
    Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Esteban A Lopera MayaDepartment of Genetics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Adriaan van der GraafDepartment of Genetics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Pauline LantingDepartment of Genetics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Marije van der GeestDepartment of Genetics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Jingyuan FuDepartment of Genetics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Morris SwertzDepartment of Genetics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Lude FrankeDepartment of Genetics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Cisca WijmengaDepartment of Genetics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Patrick DeelenDepartment of Genetics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Alexandra ZhernakovaDepartment of Genetics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Serena SannaDepartment of Genetics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Lifelines Cohort Study
University of Groningen · NLUniversity Medical Center Groningen · NLNational Research Council · ITUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) shows a wide variation in expression and severity of symptoms, from very mild or no symptoms, to flu-like symptoms, and in more severe cases, to pneumonia, acute respiratory distress syndrome, and even death. Large differences in outcome have also been observed between males and females. The causes for this variability are likely to be multifactorial, and to include genetics. The SARS-CoV-2 virus responsible for the infection depends on two human genes: the human receptor angiotensin converting enzyme 2 (

Indexed as

ACE2ARBs (angiotensin II receptor blockers)COVID-19NSAIDs (non-steroidal anti-inflammatory drugs)PheWASSARS-CoV-2TMPRSS2

Identifiers

PMID32582302
PMCPMC7295011
OpenAlexW3028352948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.